Skip to content

Cognitive-guided EEG neurofeedback treatment for methamphetamine addiction

An intervention study on methamphetamine addiction using cognition guided EEG neurofeedback

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042747
Enrollment
Unknown
Registered
2021-01-27
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methamphetamine addiction

Interventions

Experimental group:Down-regulate training according to the neurofeedback signals of each participant in this group, the intervention time is 10 days
Control group:Down-regulated training based on the neurofeedback signals of the participants paired with group A, and the intervention time is 10 days
Validation group:Down-regulate training according to the neurofeedback signals of each participant in this group, the intervention time is 10 days

Sponsors

University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. In accord with the DSM-IV moderate or severe drug use standard; 2. Between the ages of 18-55 years, male; 3. Currently not using methamphetamine or any other addictive substance; 4. Use only methamphetamine (no other addictive substance) for at least one year; 5. Use methamphetamine at least 3 times a week; 6. Each using dose exceeds 0.1 g; 7. Secondary education and above, normal vision and hearing; 8. Willing to be randomly assigned to this study; 9. The place of residence is in anhui province.

Exclusion criteria

Exclusion criteria: 1. Severe physical and mental illness requiring medical treatment; 2. Other mental disorders diagnosed by dsm-iv, such as bipolar disorder, schizophrenia, depression, and SUD; 3. Suffering from diseases requiring hospitalization or regular monitoring; 4. Neurological disorders include stroke, epilepsy, migraines, and head trauma; 5. Acute suicide or suicidal ideation in the past three months; 6. Volunteers who participated in other experiments.

Design outcomes

Primary

MeasureTime frame
Drug craving score;Electroencephalogram(EEG) signal;Neurofeedback regulation;Urine test results;

Secondary

MeasureTime frame
Behavioral task;Scale scores;

Countries

China

Contacts

Public ContactXiaochu Zhang
zxcustc@ustc.edu.cn+86 551-63607295

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026